Newman Ferrara LLP has begun an investigation into whether the officers and directors of American Renal Associates Holdings, Inc. (“American Renal Associates”) (NYSE:ARA) breached their fiduciary duties to the company.

According to a complaint filed in the United States District Court in Florida’s Southern District by a health insurer, American Renal Associates engaged in a “fraudulent and illegal scheme” to extract higher reimbursement payments by convincing patients to sign up for health insurance, rather than remaining on Medicare and Medicaid, while indirectly paying premiums for those same patients. The suit seeks unspecified damages and injunctive relief.

Newman Ferrara’s investigation concerns the extent to which certain American Renal Associates’ officers and directors knew or should have known of the alleged “fraudulent and illegal scheme.”

If you hold American Renal Associates’ stock and wish to obtain additional information about the investigation and your legal rights and potential remedies, please contact Newman Ferrara attorney Roger Sachar Jr. at rsachar@nfllp.com.

Newman Ferrara maintains a multifaceted practice based in New York City with attorneys specializing in complex commercial and multi-party litigation, securities fraud and shareholder litigation, consumer protection, civil rights, and real estate. For more information, please visit the firm website at www.nfllp.com.

Newman Ferrara LLPRoger Sachar Jr., 212-619-5400

American Renal Associates (NYSE:ARA)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more American Renal Associates Charts.
American Renal Associates (NYSE:ARA)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more American Renal Associates Charts.